HCPLive Network
Latest Managed Care Headlines
Friday, October 31, 2014
The retrospective study analyzed SEER data from 2001 through 2009, and found that the annual CAD prevalence among Medicare screening mammograms increased from 3.5% to 79.7%.
Friday, October 31, 2014
The retrospective study, results of which were presented at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology, showed that the total diagnostic workup cost for the study sample of Medicare beneficiaries was $38.3 million.
Friday, October 31, 2014
An investigation into 2012 Medicare claims for HIV-infected patients unearthed payment for prescriptions that were filled up to 32 days after the patient's passing.
Friday, October 31, 2014
By Laura Joszt
In 2015, hospital readmissions will be a growing concern as the maximum penalty increases to 3% of Medicare payments. Researcher from Columbia Business School found that one extra day in the hospital can make all the difference to readmission and mortality rates.
Thursday, October 30, 2014
By Laura Joszt
Kindred Healthcare, Inc’s chief operating officer and president, Benjamin A. Breier will take over as chief executive officer next year, just after the company is expected to close its acquisition of Gentiva Health Services.
Thursday, October 30, 2014
Phase 2 results from the Checkmate-063 trial found that treatment with the PD-1 inhibitor Nivolumab (Opdivo) resulted in a median OS of 8.2 months in NSCLC patients who had received 2 prior treatments.
Thursday, October 30, 2014
By Laura Joszt
Gaps in accountable measure sets exist among some of the most prevalent and costly conditions, according to a new report from the National Pharmaceutical Council and Discern Health.
Thursday, October 30, 2014
By Laura Joszt
Panelists discussed the price of pharmaceuticals and controlling the cost of care at the 64th Annual Roy A. Bowers Pharmaceutical Conference: A Measured Approach—Health Care Delivery and Transformation in a Metric Driven World, held by Rutgers University.
Thursday, October 30, 2014
The European Medicines Agency granted an orphan status to ATIR, a T-cell immunotherapy-based medicinal product being developed to treat blood cancers.
Thursday, October 30, 2014
The Danish study, published in the Journal of Clinical Oncology, identified a 70% greater risk of severe depression in the first year after diagnosis.
Physician's Money Digest
The end of Daylight Saving Time means an “extra” hour for most Americans. And while the vast majority of people will use that extra hour to sleep, Fidelity Investments is suggesting a different idea: Use the time to focus on your finances.
Any businessperson knows taxes can make a significant difference to their company’s bottom line. And while recent tax inversions by multinational corporations have highlighted the effects of federal tax policy, local and states taxes can also play a major role determining whether a business thrives, fails, or even relocates.